STAT-DIAGNOSTICA DEVELOPS FULLY INTEGRATED MOLECULAR AND IMMUNOASSAY DIAGNOSTIC SYSTEMS FOR CLINICAL DECENTRALIZED TESTING: IVD PRODUCTS DELIVERING IMMEDIATE & ACTIONABLE CLINICAL INFORMATION FOR IMPROVED PATIENT MANAGEMENT.

DISCOVER DIAGCORE,
END-TO-END AUTOMATION SOLUTIONS

The DiagCORE platform is designed to meet the requirements of decentralized testing environments without compromising assay quality and performance. Our systems deliver true walk-away solutions in single-test consumables offering end-to-end sample to results with the shortest turnaround times.

SCROLL DOWN TO KNOW MORE

CRITICAL CARE
& STAT TESTING


We focus on Critical Care diagnostic solutions delivering high sensitivity tests targeting primarily hospital settings such as Emergency Departments, Intensive Care Units or STAT labs.

DECENTRALIZATION
& RANDOM ACCESS


DiagCORE is a versatile system designed to meet the needs of Near Patient Testing for low test volumes or as a platform to cover mid throughput requirements for small and large-sized hospitals.

QUALITY
& PERFORMANCE


STAT-Diagnostica strives to develop Best-in-Class products providing reliable and safe diagnostics with the highest industry standards.

PRODUCTS

DiagCORE is conceived to operate in Near Patient Testing environments for acute care settings. Our products will offer molecular and immunoassay consolidated diagnostics with plug-&-play connectivity to Hospital and Laboratory Information Systems for improved streamlined workflows. STAT-Diagnostica develops user-friendly and very cost effective tests providing:

- Faster test turnaround times from sample to results.

- Broad menu capabilities from a variety of specimens on a single platform.

- Systems designed to meet CLIA-waived guidelines.

ANALYZER


The DiagCORE analyzer is a small-foot print and portable system running on consumable test cartridges. The system is modular and upgradable to handle low to mid throughput requirements providing Random Access capabilities with remarkably low maintenance needs. The analyzers have no wet interfaces with the test cartridges eliminating all cross-contamination sources while avoiding the need of cumbersome and costly post-PCR rooms.

TEST CARTRIDGES


The DiagCORE test cartridges contain all wet and dry chemistries onboard providing shelf-life stabilities of 12-months at room temperature. The test cartridges automate all sample preparation processes from various specimen types with volumes ranging from 0.1 to 1.5 mL.

The STAT-Molecular

This test cartridge automates sample homogenation, cell disruption, nucleic acid purification, and delivers up to 50-plex target detection employing qPCR. Sample to Result in under 30 minutes.

This test cartridge is designed to automate a wide range of molecular assays in the fields of infectious diseases, oncology, coagulation, prenatal, inherited diseases or companion diagnostics.

The STAT-Immuno

This test cartridge performs onboard plasma separation and is capable of detecting 4 analytes with lab-quality sensitivities employing Time Resolved Fluorescence techniques. Sample to Result in under 15 minutes.

This test cartridge is designed to automate high-sensitivity immunoassays for critical care markers such as Procalcitonin (Sepsis), Troponin (AMI), Ngal (AKI), C-reactive protein (Inflammation), hCG (pregnancy), among others.

WE ADDRESS CLINICAL APPLICATIONS AND DISEASES,
WHERE FAST AND ACCURATE DIAGNOSTICS TRANSLATE INTO ENHANCED MEDICAL DECISION MAKING.

TECHNOLOGY PROVIDING...

FULL AUTOMATION
& LOW COST OF GOODS
guaranteeing error-free results for cost efficient 24-7 operations.

AN OPEN
ARCHITECTURE SYSTEM
accepting many standard chemistries for fast Time to Market of new assays.

CLIA-WAIVED DESIGNS
with short Time of Result for improved patient triage and stratification.

SUPERIOR SAMPLE PREPS
involving mechanical cell disruption or automated swab elution for lab-quality performances.

SYSTEM FLEXIBILITY
offering large multiplex qualitative results or absolute qPCR quantification capabilities.

PANEL-MULTIPLEXED SOLUTIONS
shifting from specific pathogen detection to Syndromic- Approach diagnostics.

IVD SOLUTIONS
permitting MDx test migration from the central lab to small and mid-sized hospitals.

NEWS & MEDIA

May 6th 2013
STAT-Diagnostica closes a 17 M€
Series B investment round

June 19th 2013
STAT-Diagnostica Names
Gérard Vaillant as Board Chairman

CONTACT

STAT-DIAGNOSTICA & INNOVATION

Baldiri Reixac 4, Barcelona (Spain)
T: +34 93 448 51 24
F: +34 93 448 87 68
info@stat-diagnostica.com

WORK WITH US

If you are a professional with relevant expertise in the fields of in-vitro diagnostics or medical device technologies, we would be interested in knowing you better.

CONTACT US